In addition to publishing newsletters on a regular basis, Edlescher issues advisories and alerts to keep our clients informed of breaking news and legal developments.
To receive our publications, please email info@edlescher.com.
The Portugal Golden Visa Program is one of the most popular residency by investment programs in Europe and in the world. The program offers residency in Portugal after the investor makes a significant
On April 29, 2025, the Court of Justice of the European Union delivered a landmark judgment in Commission v Malta, ruling that Malta’s investor citizenship scheme, commonly known as the “golden
China’s commerce minister, Wang Wentao, has called for increased dialogue and cooperation between China and the United Kingdom (TADAWUL:4280) in areas such as sustainability, digital development,
Press Release from Carey Olsen, Friday 30 May, 2025. Carey Olsen partners Tim Haynes, Helen Wang and Matthew Watson, and counsel Kate Lan and Amelia Tan have featured in the Asian Legal Business (“ALB”)
Brazil has ended its tax exemption for small-scale crypto profits, introducing a 17.5% flat rate on all capital gains from digital assets. The new rule was announced under Provisional Measure 1303 as
Cyprus is preparing a sweeping tax overhaul that will broaden the tax base, toughen enforcement and ease the burden on households and businesses, officials familiar with the draft legislation said.
EU institutions agreed Wednesday on a legislative simplification plan that will remove the majority of companies from the scope of the carbon tax at the border. The European Council announced that an
British and American tourists could pay higher fees to enter the EU under a plan to boost the bloc’s tax revenues. The EU is considering taxing foreign travelers to pay back part of the €350 billion
South Africa is one step closer to leaving the FATF grey list as it has completed all required reforms and now awaits a final on-site visit before possible removal at the October 2025 meeting. In 2023,
Two Democratic lawmakers on Tuesday pressed five of the nation’s largest pharmaceutical companies about their low tax bills and whether they support extending massive tax cuts for the industry